Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Capital Employed: 2024

Historic Return on Capital Employed for Silence Therapeutics (SLN) over the last 1 years, with Dec 2024 value amounting to 0.44%.

  • Silence Therapeutics' Return on Capital Employed was N/A to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year change of. This contributed to the annual value of 0.44% for FY2024, which is N/A change from last year.
  • Latest data reveals that Silence Therapeutics reported Return on Capital Employed of 0.44% as of FY2024.
  • In the past 5 years, Silence Therapeutics' Return on Capital Employed registered a high of 0.44% during FY2024, and its lowest value of 0.44% during FY2024.